The Technology in M&A team at KPMG is one of the fastest growing and most profitable within Deal Advisory and across the firm. We deal with all aspects of technology, from strategy, digital, apps, infrastructure, cloud, operating models, data, cyber, RPA and post deal implementation & enhancements to reviewing technology spend.

KPMG is one of the world's largest and most respected consultancies.  We've supported the UK through times of war and peace, prosperity and recession, political and regulatory upheaval. We've proudly stood beside the institutions and businesses which make the UK what it is.

The UK ServiceNow Alliance Lead is responsible for managing and developing the strategic partnership between KPMG and ServiceNow, focusing on driving business growth by leveraging ServiceNow solutions to deliver client services across various industries, including identifying new sales opportunities, leading joint go-to-market initiatives, and ensuring seamless integration between KPMG's expertise and ServiceNow's technology offerings.

We require an outstanding Alliance professional, with extensive client facing experience, knowledge of the people and propositions associated with ServiceNow and the sales leadership skills to drive the growth that the ServiceNow business presents to KPMG.

KPMG’s Strategy & Performance Transformation team is looking for an exceptional Associate Director with a Healthcare and Life Sciences focus and experience of at least one of our core propositions; Growth Strategy, Deal Strategy and Operational Strategy. 

The Strategy & Performance Transformation team is part of KPMG’s rapidly expanding Strategy Group, which delivers value for clients by challenging conventional thinking, bringing deep industry and functional insights and executing with investor-grade rigour. We are a diverse team of over 170 practitioners, working collaboratively with and orchestrating KPMG’s broad set of capabilities within our Deal Advisory business.

Within the Strategy & Performance Transformation team we have an established Healthcare and Life Sciences practice. We are seeking an Associate Director to join the team who is a professional, talented individual with a passion for identifying and creating innovative solutions for clients. 

In Healthcare and Life Sciences we focus on Commercial Strategy, which includes, for example, launch and commercialisation strategy and transformation, pricing and market access, portfolio strategy, competitive strategy and LoE strategy. In terms of inorganic growth, we work both buy side and sell side, supporting our clients throughout the life cycle of a transaction including target identification, red flag analysis, commercial due diligence, business planning etc.

As a team, we are a group of bright committed individuals who are passionate about delivering fantastic client work, developing the team around us and having fun both inside and outside of work.

KPMG’s Deal Execution practice is looking for exceptional candidates for an Associate Director role, with a technology, digital, AI and M&A specialisation.

Associate Director - Deal Execution - Integration & Separation

KPMG’s Deal Execution practice is looking for exceptional candidates for an Associate Director role. The Deal Execution team is part of KPMG’s rapidly expanding Strategy Group, which delivers value for clients by challenging conventional thinking, bringing deep industry and functional insights and executing with investor-grade rigour.  We are a diverse team working collaboratively with and orchestrating KPMG’s broad set of capabilities within our Deal Advisory business, and are focused on continually enhancing value for clients across the deal and economic cycle. Our teams comprise of specialists capable of helping clients right through from conceptual thinking of buying a business to turning their business around in times of difficulty.

The Deal Execution Advisory Team

KPMG's Deal Execution Advisory Team is a growing and dynamic team. We work with both vendors and acquirers on mergers, acquisitions, divestments, exits and joint ventures, both pre and post-deal.

The team offers four key proposition areas:

Separation: Supporting vendors to plan and deliver a credible, discrete standalone entity to the Buyer with value preserved and business continuity in place from Day 1, including supporting the definition and implementation of transitional service agreements.

Integration: Pre and post deal integration design, planning and implementation to integrate the target business into the Buyer’s organisation whilst mitigating risk and enhancing value.

Synergies: Understanding the potential benefits and costs generated through a proposed transaction, and the associated plans, interdependencies, risks and issues for the delivery of base and stretch case targets.

Joint Ventures: Helping respective partners ensure the key value considerations are identified and prioritised early and delivered through the associated business plan, leveraging each party’s specific contribution and capabilities and managing broader stakeholder relationships.